Literature DB >> 9652729

Cytokine gene activity in AML cells in vivo in patients.

X Z Gao1, S Bi, H Copra, E Devemy, P Venugopal, B Li, W T Hsu, J Loew, A Galvez, S Gregory, J Yang, E Horvath, H D Preisler.   

Abstract

The proliferation of acute myelogenous leukemia cells is dependent upon cytokine stimulation. Additionally, there is a body of literature which reports that leukemia cells produce GMCSF, IL6, and other cytokines. The study reported here, using an rt-multiplex polymerase method, determined the presence or absence of transcripts in freshly obtained AML cells for the following cytokine or cytokine-related genes: IL 1beta, IL1ra, TNF alpha, GMCSF, IL6, flt 3, and hSCF. This demonstrated that leukemia cell populations usually contain transcripts for IL1beta, TNF alpha, flt 3 and flt 3 ligand in vivo and that transcripts for the other cytokines only appear after the leukemia cells are processed in vitro. The presence of TNF alpha transcripts appears to be associated with resistance to remission induction therapy. Furthermore, the transcript profile of the leukemia cells can change during remission induction therapy. The data also demonstrate the assessment of cytokine production by leukemia cells after in vitro manipulation should not be extrapolated to the in vivo situation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652729     DOI: 10.1016/s0145-2126(98)00024-1

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  6 in total

1.  Commonly dysregulated genes in murine APL cells.

Authors:  Wenlin Yuan; Jacqueline E Payton; Matthew S Holt; Daniel C Link; Mark A Watson; John F DiPersio; Timothy J Ley
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

Review 2.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

3.  PARC/CCL18 is a plasma CC chemokine with increased levels in childhood acute lymphoblastic leukemia.

Authors:  Sofie Struyf; Evemie Schutyser; Mieke Gouwy; Klara Gijsbers; Paul Proost; Yves Benoit; Ghislain Opdenakker; Jo Van Damme; Geneviève Laureys
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

4.  IL-32θ gene expression in acute myeloid leukemia suppresses TNF-α production.

Authors:  Man Sub Kim; Jeong-Woo Kang; Jae-Sik Jeon; Jae Kyung Kim; Jong Wan Kim; Jintae Hong; Do-Young Yoon
Journal:  Oncotarget       Date:  2015-12-01

5.  Bone marrow injury induced via oxidative stress in mice by inhalation exposure to formaldehyde.

Authors:  Yuchao Zhang; Xudong Liu; Cliona McHale; Rui Li; Luoping Zhang; Yang Wu; Xin Ye; Xu Yang; Shumao Ding
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

6.  Assessment of cytokine expression profile in acute myeloid leukemia patients before and after chemotherapy.

Authors:  Zargham Sepehrizadeh; Mohammad Mohammadi; Amirhossein Emami; Mojtaba Tabatabaei Yazdi; Saeed Hashemi Bozchlou; Mohammad Reza Khorramizadeh; Mina Bahrololoumi Shapourabadi; Elham Jaberi; Naghmeh Rajaei; Neda Setayesh
Journal:  Turk J Haematol       Date:  2014-06-10       Impact factor: 1.831

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.